MARKETING RESEARCH OF VENOPROTECTIVE DRUG DETRALEX

MARKETING RESEARCH OF VENOPROTECTIVE DRUG DETRALEX

Authors

  • TEA ZARQUA
  • MAIA BERIDZE
  • IRINE KEKELIDZE

DOI:

https://doi.org/10.52340/jecm.2023.01.17

Keywords:

Marketing research, venoprotective, drug, Detralex

Abstract

 As of today, varicose veins occur in 10-40% of the working population of developed countries. The most effective means of managing this pathology is venoprotective drugs. The purpose of the research was the marketing analysis of the drug "Detralex", which revealed that the majority of patients know and have used Detralex, applies self-medication and takes responsibility for his own health. When choosing medicines, the price is a priority for the majority of patients, which is caused by the social situation in the country.

Downloads

Download data is not yet available.

References

ხარკევიჩი დ. ფარმაკოლოგია// თბილისი 2008 წ.

ფარმაცევტული კომპანია servier.

Котлер Ф. Основы маркетинга – Москва. 1996.

Mkurnali.ge

Downloads

Published

2023-03-02

How to Cite

ZARQUA, T., BERIDZE, M., & KEKELIDZE, I. (2023). MARKETING RESEARCH OF VENOPROTECTIVE DRUG DETRALEX. Experimental and Clinical Medicine Georgia, (1). https://doi.org/10.52340/jecm.2023.01.17

Issue

Section

Articles

Most read articles by the same author(s)

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.

Loading...